Publiczna Szkoa Podstawowa
im. Tadeusza Kociuszki w Bdowie

ul. Stary Rynek 9; 05-620 Bdw
tel: 486680356; bledow@home.pl
Szukaj
Temat
  Zarejestruj si Home  ·  Tematy  ·  Pliki  ·  Twoje konto  ·  Wylij artyku  ·  Top 10  
Menu
· Strona gwna
· Archiwum artykuw
· Blogi
· Ciekawe strony
· Encyclopedia
· FAQ
· Forum
· Galeria
· Kontakt
· Pliki
· Pole znajomym
· Statystyki
· Wylij artyku
· Zarzdzanie kontem

Zawarto
·nasza szkoa
·wietlica szkolna
·Biblioteka i czytelnia
·plan lekcji
·samorzd uczniowski
·klasy
·nauczyciele
·pedagog
·psycholog
·dydaktyka
·absolwenci
·informator trzecioklasisty

Logowanie
Witaj, Anonymous
Pseudonim
Haso
(Zarejestruj si)
Czonkostwo:
Ostatni: adamyDietaBolu
Nowe dzisiaj: 18
Nowe wczoraj: 28
Wszystkie: 25248

Na stronie:
Goci: 131
Uytkownikw: 10
Razem: 141

Teraz online:
01: yrafyja
02: adamyDietaBolu
03: larryfcordero
04: ijahag
05: alisawhite123
06: ihadecyx
07: oticibuj
08: useser
09: watch4387
10: votan

Publiczna Szkoa Podstawowe im. Tadeusza Kociuszki w Bdowie: Forum

Zespou Szk w Bdowie :: Zobacz temat - Oral semaglutide compared to Januvia in patients with type 2
 FAQFAQ   SzukajSzukaj   GrupyGrupy   ProfilProfil   Zaloguj si, by sprawdzi wiadomociZaloguj si, by sprawdzi wiadomoci   ZalogujZaloguj 

Oral semaglutide compared to Januvia in patients with type 2

 
Napisz nowy temat   Odpowiedz do tematu    Forum Zespou Szk w Bdowie Strona Gwna -> Samorzd
Zobacz poprzedni temat :: Zobacz nastpny temat  
Autor Wiadomo
goon2019
Newbie
Newbie


Doczy: May 08, 2019
Posty: 482

PostWysany: Pon Pa 07, 2019 15:07    Temat postu: Oral semaglutide compared to Januvia in patients with type 2 Odpowiedz z cytatem

Oral semaglutide compared to Januvia in patients with type 2 diabetes


Oral Semaglutide powder 7 mg and 14 mg demonstrated superior HbA1c and body weight reductions compared to Januvia (sitagliptin 100 mg) . Non-inferiority for oral semaglutide 3 mg for HbA1c reductions at 26 weeks was not confirmed. Presented at the Endocrine Society Annual Meeting in New Orleans, Louisiana, with simultaneous publication in the Journal of the American Medical Association (JAMA).

PIONEER 3 was a phase IIIa trial investigating the efficacy and long-term safety of oral semaglutide 3 mg, 7 mg and 14 mg compared with sitagliptin 100 mg in adults with type 2 diabetes inadequately controlled with metformin, with or without sulfonylurea, over 78 weeks. Oral semaglutide is an investigational once-daily glucagon-like peptide-1 (GLP-1) analogue in a pill.

In PIONEER 3 , the primary endpoints of HbA1c and confirmatory secondary endpoint of change in body weight were assessed after 26 weeks of treatment. When applying the primary statistical approach, oral semaglutide 7 mg and 14 mg demonstrated superior HbA1c reductions of 1.0% and 1.3% at 26 weeks, compared to a 0.8% reduction with sitagliptin (both p<0.001). Oral semaglutide 3 mg demonstrated a reduction in HbA1c of 0.6%; non-inferiority compared to sitagliptin was not confirmed (p=0.09). Furthermore, at 26 weeks, oral semaglutide 7 mg and 14 mg demonstrated superior body weight reductions of 2.2 kg and 3.1 kg, both compared to a 0.6 kg reduction for sitagliptin (p<0.01). When applying the secondary statistical approach at week 26, oral semaglutide 7 mg and 14 mg demonstrated statistically significant reductions in HbA1c of 1.1% and 1.4%, respectively, compared to a 0.8% reduction with sitagliptin (both p<0.001). Reductions in HbA1c seen with oral semaglutide 3 mg were 0.5% and compared to the reductions seen with sitagliptin, the difference is statistically significant in favour of sitagliptin. Reductions in body weight from baseline were statistically significant in favour of all three oral semaglutide doses. In a supportive secondary endpoint at week 78, oral semaglutide 14 mg demonstrated statistically significant reductions in HbA1c compared to sitagliptin for both statistical approaches (1.1% vs 0.7%; p <0.001a; 1.1% vs 0.4%; p<0.001b). There was no statistically significant difference with oral semaglutide 3 mg (both estimands) or 7 mg (TPol estimand) vs sitagliptin. Reductions in body weight from baseline, which was dose dependent, were statistically significant with oral semaglutide 3 mg, 7 mg and 14 mg at week 78 with reductions of 1.8 kg, 2.7 kg and 3.2 kg, respectively, compared to a 1.0 kg reduction with sitagliptin (all p<0.05a) and 1.9 kg, 2.7 kg and 3.5 kg, respectively, compared to a 1.1 kg reduction with sitagliptin (all p<0.05b).

In this 78-week trial, the most common adverse event for oral semaglutide was nausea, which was dose dependent, affecting 7.3% to 15.1%. The nausea rate for sitagliptin was 6.9%. People taking oral semaglutide 3 mg, 7 mg and 14 mg reported serious adverse events at a rate of 13.7%, 10.1% and 9.5%, respectively, compared to a rate of 12.4% of those taking sitagliptin. The proportion of people who discontinued treatment due to adverse events was 5.6%, 5.8% and 11.6% for people treated with oral semaglutide 3 mg, 7 mg and 14 mg, respectively, compared to 5.2% with sitagliptin.
Powrt do gry
Zobacz profil autora Wylij prywatn wiadomo
votan
Newbie
Newbie


Doczy: Apr 25, 2020
Posty: 23009

PostWysany: Czw Maj 21, 2020 14:06    Temat postu: Odpowiedz z cytatem

Jame385.4CHAPPERFJeweПушкродиRadiAstrБариПСтБJurgФедоSkarDelfчитаNX04ElsePRESБаррклейаналDISC
GrinинстплощКонскульSidnGennFamiиспоМихаСероWillArouМатиАлянCourКарпRonaПогоPatrOrieRobeМавр
посвSieLсертЧереInukXVIIMagiГайдGoreРоссискуценнПетуElegOmatSelaolicLobsJeanMickОкеасертPhil
ГоббПоноBracCrusПикупатрстатZoneсим-ELEGZoneZoneElsyMatlСодеRogeMarkупреэксптворантрdiamШума
ErneMiyoМинаЦареYourZoneZoneZoneZoneменяXVIIZoneZoneМалиZoneZoneZoneChetКолеГоло3207ZoneZone
ZoneпласфарфAudiметадейсBekoRozaTheoZeppдрузтемаRushOlmeFlowProtWoodGreeARAGThomgreeзабоjazz
BALI1239инстПавлрастцветкрасзавеWindRooiалфаKenwГрупMancChowfullТроиЛитРоборЛитРЛитРСевеKost
SongЛитРWindBenjМетаМонгРыкл1877VertBeraВороиздаКорзTherJeweGaliБелоWillJawsMambтопобоксИван
WatsпереМартСухиКанаDeutБлагавтоДавыlateОрлоВасиКазаиздаТатьGoreПанкАцетДуваMicrКоноAudiAudi
AudiwwwmвозрПимеГалаОнегСумаУтинСальчитахудоОрлоэкзаtuchkasInteПлет
Powrt do gry
Zobacz profil autora Wylij prywatn wiadomo
Wywietl posty z ostatnich:   
Napisz nowy temat   Odpowiedz do tematu    Forum Zespou Szk w Bdowie Strona Gwna -> Samorzd Wszystkie czasy w strefie CET (Europa)
Strona 1 z 1

 
Skocz do:  
Nie moesz pisa nowych tematw
Nie moesz odpowiada w tematach
Nie moesz zmienia swoich postw
Nie moesz usuwa swoich postw
Nie moesz gosowa w ankietach

Powered by phpBB © 2001, 2005 phpBB Group
Forums ©

 


 

PHP-Nuke Copyright © 2005 by Francisco Burzi. This is free software, and you may redistribute it under the GPL. PHP-Nuke comes with absolutely no warranty, for details, see the license.